{"transactions":[{"id":1103244,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:13:04.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":14164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2026 annual meeting of the Company's stockholders or June 20, 2026."}],"balance_after":50258,"source":{"system":"sec-edgar","filing":"0001171843-25-004070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184325004070/ownership.xml","form_type":"4"}},{"id":1456514,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-11T20:34:02.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":5771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2025 annual meeting of the Company's stockholders or July 9, 2025."}],"balance_after":36094,"source":{"system":"sec-edgar","filing":"0001171843-24-003908","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184324003908/ownership.xml","form_type":"4"}},{"id":1853245,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:16:39.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2024 annual meeting of the Company's stockholders or June 14, 2024."}],"balance_after":30323,"source":{"system":"sec-edgar","filing":"0001171843-23-003960","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184323003960/ownership.xml","form_type":"4"}},{"id":2236782,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T20:16:43.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":7954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023."}],"balance_after":23823,"source":{"system":"sec-edgar","filing":"0001171843-22-004300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184322004300/ownership.xml","form_type":"4"}},{"id":2662151,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:17:39.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":4172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2022 annual meeting of the Company's stockholders or June 16, 2022."}],"balance_after":15869,"source":{"system":"sec-edgar","filing":"0001171843-21-004428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184321004428/ownership.xml","form_type":"4"}},{"id":3244748,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T23:51:09.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":4107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021."}],"balance_after":11697,"source":{"system":"sec-edgar","filing":"0001171843-20-001360","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184320001360/ownership.xml","form_type":"4"}},{"id":3426232,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-30T20:05:27.000Z","date":"2019-08-28","kind":"sale","acquired":false,"shares":4355,"price":57.21,"value":249149.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price. The shares were sold on 8/28/19 at prices ranging from $57.14 to $57.34 per share. Full information regarding the number of shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request."}],"balance_after":7590,"source":{"system":"sec-edgar","filing":"0001171843-19-005733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319005733/ownership.xml","form_type":"4"}},{"id":3627463,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:35:29.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":3842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020."}],"balance_after":11945,"source":{"system":"sec-edgar","filing":"0001171843-19-001390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001390/ownership.xml","form_type":"4"}},{"id":4088836,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-26T21:09:23.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":1626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 24, 2019."}],"balance_after":8103,"source":{"system":"sec-edgar","filing":"0001171843-18-000694","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000694/formfour.xml","form_type":"4"}},{"id":4475946,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":78210,"kind":"person","name":"Larsen Glenn R.","position":1,"cik":"0001633737","reported_name":"Larsen Glenn R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-31T21:09:33.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares represent restricted stock units.  Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock.  The restricted stock units vest in full on January 27, 2018."}],"balance_after":6477,"source":{"system":"sec-edgar","filing":"0001171843-17-000589","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000589/formfour.xml","form_type":"4"}}]}